Oracle CEO Unveils AI-Powered Personalized Cancer Vaccines “`

Larry Ellison announced the initiative at the White House during President Donald Trump’s unveiling of a $500 billion AI infrastructure project.

Oracle’s CEO, Larry Ellison, revealed his company’s development of an AI-powered system for creating personalized cancer vaccines. He emphasized that this AI allows for the robotic production of mRNA vaccines in approximately 48 hours.

Ellison’s remarks were made during a White House event where President Trump announced Stargate, a new $500 billion investment in AI infrastructure, alongside Ellison, OpenAI CEO Sam Altman, and SoftBank CEO Masayoshi Son.

Ellison welcomed the program, stating that a key project utilizes technology from Altman and Son to develop a cancer vaccine. This approach uses AI to initially detect cancer fragments in blood samples.

Messenger RNA (mRNA) molecules provide the genetic instructions for cells to create proteins.

Beyond early detection, Ellison explained that after gene sequencing the tumor, a personalized vaccine can be designed for each patient to target their specific cancer.

OpenAI CEO Sam Altman similarly predicted rapid advancements in cancer and heart disease treatments.

President Trump lauded Stargate as a significant undertaking, boosting American technological leadership and creating approximately 100,000 jobs, while countering China’s technological advancements.

Ellison mentioned that initial Stargate data centers are under construction in Texas.

One of President Trump’s first actions was to overturn a 2023 executive order by President Biden aimed at mitigating AI risks.

Last week, MIT Technology Review reported that OpenAI, with Retro Biosciences, created GPT-4b micro, a language model assisting scientists in extending human lifespan.

This technology reportedly enhances protein redesign, improving stem cell production, crucial for regenerative medicine and treating age-related illnesses due to stem cells’ ability to differentiate into various cell types.